Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)
NCT ID: NCT07213245
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
24 participants
INTERVENTIONAL
2025-12-01
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A total of 24 men and women who meet all inclusion criteria and none of the exclusion criteria will be invited to participate. A randomized 2\*2 factorial four-way crossover study will be conducted at the Department of Internal medicine and Clinical Nutrition at the University of Gothenburg, comparing a high-UPF meal to a low-UPF meal also with high and/or low energy density. A supervised breakfast meal will be served, and postprandial blood samples and appetite measures will be collected continuously up to 4 hours after the breakfast meal. Subsequently, an ad libitum lunch meal will be served, and energy intake will be recorded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Ultra Processed Versus Unprocessed Diets on Energy Intake
NCT03407053
Effect of Ultra-processed Versus Unprocessed Diets on Energy Metabolism
NCT05290064
Determinants and Outcomes of High vs. Low Ultra-processed Feeding
NCT06310603
Impact of the Eating Rate of Ultra-processed Foods on Dietary Intake Behavior and Metabolic Responses
NCT06113146
Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance
NCT05337007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meal high in energy density, high in ultra-processed food
Meal high in energy density, high in ultra-processed food
Meal high in energy density, high in ultra-processed food
Meal high in energy density, high in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, low in ultra-processed food
Meal low in energy density, low in ultra-processed food
Meal low in energy density, low in ultra-processed food
Meal low in energy density, low in ultra-processed food
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meal high in energy density, high in ultra-processed food
Meal high in energy density, high in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal high in energy density, low in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, high in ultra-processed food
Meal low in energy density, low in ultra-processed food
Meal low in energy density, low in ultra-processed food
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting glucose \< 6.1 mmol/l
* Hb \>110 g/L
* Weight stability the last 3 months +/-5%
Exclusion Criteria
* Unable to sufficiently understand written and spoken Swedish or English to provide written consent and understand information and instructions from the study personal.
* Pregnant, lactating or planning a pregnancy during the study period.
* Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study.
* History of gastrointestinal conditions or major gastrointestinal surgery (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.).
* Type 1 diabetes or type 2 diabetes.
* Thyroid disorder.
* Current smoking, vaping.
* Following any weight reduction program or having followed one during the last 6 months prior to screening.
* Not habitually eating breakfast (\<5 times/week).
* Restrained eating based on the three-factor eating questionnaire.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Therese Karlsson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Gothenburg, Institute of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of internal medicine and clinical nutrition, University olf Gothenburg
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Therese Karlsson, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEST-UPF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.